Beta-glucan-depleted, glycopeptide-rich extracts from Brewer’s and Baker’s yeast (Saccharomyces cerevisiae) lower interferon-gamma production by stimulated human blood cells in vitro

Beta-glucan-depleted, glycopeptide-rich extracts from Brewer’s and Baker’s yeast (Saccharomyces cerevisiae) lower interferon-gamma production by stimulated human blood cells in vitro

Food Chemistry, November 2015

26617014

Roderick Williams, Daniel A. Dias, Nirupama Jayasinghe, Ute Roessner, Louise E. Bennett

Regulation of the human immune system requires controlled pro- and anti-inflammatory responses for host defence against infection and disease states. Yeasts (Saccharomyces cerevisiae), as used in brewing and baking, are mostly known for ability to stimulate the human immune-system predominantly reflecting the pro-inflammatory cell wall β-glucans. However, in this study, using food-compatible processing methods, glycopeptide-enriched and β-glucan-depleted products were each prepared from Brewer's and Baker's yeasts, which suppressed production of interferon-γ (IFN-γ) in human whole blood cell assay, signifying that anti-inflammatory factors are also present in yeast. Anti-inflammatory bioactivities of products prepared from Brewer's and Baker's yeast were compared with the commercial yeast product, Epicor®. While unfractionated Epicor was inactive, the C18 resin-binding fractions of Brewer's and Baker's yeast products and Epicor dose-dependently lowered IFN-γ, demonstrating that Epicor also contained both pro-inflammatory (β-glucans) and anti-inflammatory components. Anti-inflammatory activity was attributed to C18 resin-binding species glyco-peptides in Epicor and experimental yeast products. This study demonstrated that pro- and anti-inflammatory factors could be resolved and enriched in yeasts by suitable processing, with potential to improve specific activities.